STOCK TITAN

DocGo (DCGO) insider reports 321,055 RSU grant and tax withholding

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

DocGo Inc.'s chief compliance officer, Stephen Sugrue, reported new equity awards and related tax withholding. On December 12, 2025, he received 321,055 restricted stock units (RSUs) under the 2021 Stock Incentive Plan, vesting in four equal annual installments starting on the first anniversary of that date. Each RSU represents the right to receive one share of common stock upon vesting.

On December 15, 2025, 35,968 RSUs were withheld at a price of $0.91 per share to satisfy his tax liability from earlier RSU grants. After these transactions, Sugrue beneficially owns 636,602 shares of DocGo common stock, including additional RSUs scheduled to vest between December 2026 and December 2028.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sugrue Stephen

(Last) (First) (Middle)
C/O DOCGO INC
685 THIRD AVENUE, 9TH FLOOR

(Street)
NEW YORK NY 10017

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
DocGo Inc. [ DCGO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Compliance Officer
3. Date of Earliest Transaction (Month/Day/Year)
12/12/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/12/2025 A 321,055(1) A $0 672,570(2) D
Common Stock 12/15/2025 F 35,968(3) D $0.91 636,602(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). The RSUs will vest in four equal annual installments on each of the first four anniversaries of December 12, 2025, subject to the terms of the Plan. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan.
2. In addition to the RSUs granted on December 12, 2025, this amount reflects: (i) 80,549 RSUs granted pursuant to the Plan that will vest in three equal annual installments on each of December 12, 2026, December 12, 2027 and December 12, 2028; and (ii) 87,209 RSUs granted pursuant to the Plan that will vest in two equal annual installments on each of December 12, 2026 and December 12, 2027, in each case subject to the terms of the Plan. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan.
3. The reported transaction reflects the withholding of RSUs in satisfaction of the Reporting Person's tax liability. The RSUs were granted to the Reporting Person on December 12, 2023 and December 12, 2024 pursuant to the Plan.
Remarks:
/s/ Jerilyn Laskie, as Attorney-in-Fact for Stephen Sugrue 12/16/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did DocGo (DCGO) disclose for its chief compliance officer?

The filing shows that Stephen Sugrue, DocGo's chief compliance officer, reported a new grant of restricted stock units and a separate tax-related RSU withholding transaction.

How many RSUs did Stephen Sugrue receive from DocGo (DCGO) on December 12, 2025?

On December 12, 2025, Sugrue received 321,055 restricted stock units (RSUs) under DocGo's 2021 Stock Incentive Plan.

What are the vesting terms of the new DocGo (DCGO) RSU grant?

The 321,055 RSUs granted on December 12, 2025 will vest in four equal annual installments on each of the first four anniversaries of that date, subject to the plan's terms.

Why were 35,968 DocGo (DCGO) RSUs withheld on December 15, 2025?

The 35,968 RSUs reported on December 15, 2025 were withheld at $0.91 per share to satisfy Sugrue's tax liability arising from RSUs granted on December 12, 2023 and December 12, 2024.

How many DocGo (DCGO) shares does Stephen Sugrue beneficially own after these transactions?

Following the reported transactions, Sugrue beneficially owns 636,602 shares of DocGo common stock, which includes RSUs that are scheduled to vest between December 2026 and December 2028.

What additional RSU awards from DocGo (DCGO) are scheduled to vest in future years?

Beyond the new grant, the filing notes 80,549 RSUs vesting in three equal annual installments on December 12, 2026, 2027, and 2028, and 87,209 RSUs vesting in two equal annual installments on December 12, 2026 and 2027, all under the 2021 Stock Incentive Plan.

DOCGO INC

NASDAQ:DCGO

DCGO Rankings

DCGO Latest News

DCGO Latest SEC Filings

DCGO Stock Data

72.91M
88.43M
7.31%
52.38%
4.13%
Medical Care Facilities
Services-health Services
Link
United States
NEW YORK